Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 25,000 shares at $0.99 ($25K) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Open-market purchase of $25k MAIA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.99 | 10,000 | $10K | 40.2% |
| 2 | $0.98 | 15,000 | $15K | 59.8% |
| Total | $0.98 avg | 25,000 | $25K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |